Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer

NCT00932152 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Poor enrollment/suspended to accrual; will close per AstraZeneca request

Conditions

Non-small Cell Lung Cancer
Postmenopausal Women

Interventions

DRUG: fulvestrant (Faslodex)
DRUG: anastrozole (Arimidex)
DRUG: Bevacizumab (Avastin)
DRUG: Best supportive care

Sponsor

University of Pittsburgh